CROSSJECT SA EO -10
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster he… Read more
Market Cap & Net Worth: CROSSJECT SA EO -10 (74C)
CROSSJECT SA EO -10 (F:74C) has a market capitalization of $105.38 Million (€102.67 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #18284 globally and #1911 in its home market, demonstrating a 3.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CROSSJECT SA EO -10's stock price €1.97 by its total outstanding shares 52167239 (52.17 Million).
CROSSJECT SA EO -10 Market Cap History: 2015 to 2026
CROSSJECT SA EO -10's market capitalization history from 2015 to 2026. Data shows change from $497.26 Million to $105.38 Million (-6.60% CAGR).
CROSSJECT SA EO -10 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CROSSJECT SA EO -10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 74C by Market Capitalization
Companies near CROSSJECT SA EO -10 in the global market cap rankings as of March 19, 2026.
Key companies related to CROSSJECT SA EO -10 by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
CROSSJECT SA EO -10 Historical Marketcap From 2015 to 2026
Between 2015 and today, CROSSJECT SA EO -10's market cap moved from $497.26 Million to $ 105.38 Million, with a yearly change of -6.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €105.38 Million | -4.70% |
| 2025 | €110.58 Million | -0.24% |
| 2024 | €110.84 Million | -54.41% |
| 2023 | €243.11 Million | +38.20% |
| 2022 | €175.91 Million | +24.90% |
| 2021 | €140.83 Million | -17.43% |
| 2020 | €170.55 Million | +33.82% |
| 2019 | €127.44 Million | +110.99% |
| 2018 | €60.40 Million | -73.66% |
| 2017 | €229.30 Million | -1.07% |
| 2016 | €231.79 Million | -53.39% |
| 2015 | €497.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of CROSSJECT SA EO -10 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $105.38 Million USD |
| MoneyControl | $105.38 Million USD |
| MarketWatch | $105.38 Million USD |
| marketcap.company | $105.38 Million USD |
| Reuters | $105.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.